Stay updated on Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial
Sign up to get notified when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.

Latest updates to the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page
- CheckyesterdayChange DetectedA site-wide funding/status notice was added and the page version updated to v3.4.1, with the previous v3.4.0 tag removed.SummaryDifference0.6%

- Check8 days agoChange DetectedThe history page now shows a Show glossary option and uses green highlights for additions and red highlights for deletions, along with the Revision: v3.4.0 label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision entry v3.3.4 was added to the history and the previous entry v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedAdded a new site revision note 'Revision: v3.3.3' and removed the 'HHS Vulnerability Disclosure' link along with the previous 'Revision: v3.3.2' entry. These changes reflect backend/site policy updates rather than alterations to the trial data or history.SummaryDifference0.2%

- Check72 days agoChange DetectedAdded revision v3.3.2 and removed revision v3.2.0 from the study record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedRemoved the banner notice about lapse in government funding and NIH operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.